The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group

• Published in: Brain research Vol. 822; no. 1; pp. 1 - 7
• Main Authors: Nuseir, Khawla, Heidenreich, Byron A., Proudfit, Herbert K.
• Format: Journal Article
• Language: English
• Published: London Elsevier B.V 20.03.1999; Amsterdam Elsevier; New York, NY
• Subjects: Anesthetics, Local - pharmacology; Animals; Antimutagenic Agents - pharmacology; Biological and medical sciences; Carbachol - pharmacology; Central nervous system; Central neurotransmission. Neuromudulation. Pathways and receptors; Cholinergic Agonists - pharmacology; Cobalt - pharmacology; Cobalt chloride; Dorsolateral pontine tegmentum; Female; Fundamental and applied biological sciences. Psychology; Local anesthetic; Medulla Oblongata - chemistry; Medulla Oblongata - cytology; Medulla Oblongata - physiology; Microinjections; Neurons, Afferent - chemistry; Neurons, Afferent - drug effects; Neurons, Afferent - physiology; Nociceptors - drug effects; Nociceptors - physiology; Norepinephrine - physiology; Nucleus gigantocellularis pars α; Nucleus raphe magnus; Pain - drug therapy; Pain - physiopathology; Pons - chemistry; Pons - cytology; Pons - physiology; Raphe Nuclei - chemistry; Raphe Nuclei - cytology; Raphe Nuclei - physiology; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 - physiology; Tetracaine; Tetracaine - pharmacology; Vertebrates: nervous system and sense organs; Local anesthetic; Nucleus raphe magnus; Nucleus gigantocellularis pars α; Cobalt chloride; Dorsolateral pontine tegmentum; Tetracaine; Nociception; Agonist; Rat; Noradrenergic neuron; Rodentia; Central nervous system; Catecholamine; Analgesia; Vertebrata; Cholinergic receptor; Mammalia; Medulla oblongata; Brain (vertebrata)
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/S0006-8993(98)01195-0

Activation of neurons in the ventromedial medulla by electrical stimulation or by microinjection of opioid or cholinergic agonists produces antinociception that is mediated in part by spinally-projecting noradrenergic neurons. Several lines of evidence indicate that these noradrenergic neurons are located in the pontine A7 catecholamine cell group. For example, anatomical studies have demonstrated that neurons in the ventromedial medulla project to the noradrenergic neurons in the A7 catecholamine cell group that provide the major noradrenergic innervation of the spinal cord dorsal horn. In addition, electrical and chemical stimulation of A7 neurons produces antinociception that can be reduced by intrathecal injection of α 2-adrenoceptor antagonists. The present studies provide more direct evidence that activation of neurons in the ventromedial medulla produces antinociception by activating noradrenergic neurons in the A7 cell group. Neurons in the ventromedial medulla were stimulated by microinjecting the cholinergic agonist carbachol (5 μg) into sites in the nucleus raphe magnus or the nucleus gigantocellularis pars α of pentobarbital anesthetized Sprague–Dawley rats. In some experiments, the local anesthetic tetracaine (10 μg) was then microinjected near the A7 cell group to inactivate the spinally-projecting noradrenergic neurons. In other experiments, cobalt chloride (100 mM) was microinjected near the A7 cell group to block synaptic activation of spinally-projecting noradrenergic neurons. Microinjection of carbachol into sites in the ventromedial medulla produced antinociception, assessed using the tail flick test, that lasted more than 60 min. However, the effects of carbachol were attenuated by microinjection of either tetracaine or cobalt into sites near the A7 cell group neurons identified by tyrosine hydroxylase-immunoreactivity. Similar injections of tetracaine or cobalt more than 500 μm from the A7 neurons did not alter the antinociceptive effect of carbachol. These results support the conclusion that the antinociception produced by activating neurons in the ventromedial medulla is mediated in part by the subsequent activation of spinally-projecting noradrenergic neurons in the A7 cell group.